Bruker (BRKRP) Metrics: History & Chart

Bruker Corporation(BRKRP)

Medical - Devices · Billerica, MA

$466.08+0.30 (+0.06%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Bruker Corporation

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Billerica, MA

11,085 employees

www.bruker.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Frank H. Laukien

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-0.68%
30D Total Return	+7.96%
YTD Total Return	+31.86%
1Y Total Return	+63.24%
3Y Total Return	N/A
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+31.86%
2025	N/A
2024	N/A
2023	N/A
2022	N/A
2021	N/A

CAGR TTM	+62.86%
CAGR 3Y	N/A
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	618.50
PE Ratio Avg TTM	552.62
PE Ratio Avg 3Y	552.62
Current VS TTM Avg	+11.92%
Current VS 3Y Avg	+11.92%
Current VS 5Y Avg	+11.92%

All Metrics

BRKRP Valuation Metrics

BRKRP Stock Price Metrics

BRKRP Dividend Metrics

BRKRP Growth Rate Metrics

BRKRP Discounted Cash Flow Metrics

BRKRP Returns By Period

BRKRP Yearly Returns

BRKRP Average Annual Returns By Period (CAGR)

BRKRP Revenue Metrics

BRKRP PE Ratio Metrics

BRKRP PS Ratio Metrics

BRKRP PB Ratio Metrics

BRKRP Price to Free Cash Flow Ratio Metrics

BRKRP Debt to Equity Ratio Metrics

BRKRP PEG Ratio Metrics

BRKRP FCF Yield

BRKRP Earnings Yield

BRKRP EBITDA Yield

BRKRP OCF Yield

BRKRP EV/EBIT Ratio Metrics

BRKRP EV/EBITDA Ratio Metrics

BRKRP EV/Assets Ratio Metrics

BRKRP EV/Sales Ratio Metrics

BRKRP Current Ratio Metrics

BRKRP Quick Ratio Metrics

BRKRP ROIC Metrics

BRKRP Return on Assets Metrics

BRKRP Return on Equity Metrics

BRKRP Net Profit Margin Metrics

BRKRP Gross Profit Margin Metrics

BRKRP Tax Rate Metrics

PS Ratio	20.27
PS Ratio Avg TTM	16.13
PS Ratio Avg 3Y	15.78
Current VS TTM Avg	+25.70%
Current VS 3Y Avg	+28.43%
Current VS 5Y Avg	+28.43%

PB Ratio	29.55
PB Ratio Avg TTM	23.50
PB Ratio Avg 3Y	23.43
Current VS TTM Avg	+25.72%
Current VS 3Y Avg	+26.09%
Current VS 5Y Avg	+26.09%

PFCF Ratio	755.46
PFCF Ratio Avg TTM	1012.95
PFCF Ratio Avg 3Y	992.25
Current VS TTM Avg	-25.42%
Current VS 3Y Avg	-23.86%
Current VS 5Y Avg	-23.86%

Debt/Equity Ratio	0.80
Debt/Equity Ratio Avg TTM	0.90
Debt/Equity Ratio Avg 3Y	1.04
Current VS TTM Avg	-11.08%
Current VS 3Y Avg	-23.56%
Current VS 5Y Avg	-24.85%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	0.13%
FCF Yield Avg TTM	0.10%
FCF Yield Avg 3Y	0.11%
Current VS TTM Avg	+26.24%
Current VS 3Y Avg	+22.91%
Current VS 5Y Avg	+22.91%

Earnings Yield	0.16%
Earnings Yield Avg TTM	0.18%
Earnings Yield Avg 3Y	0.18%
Current VS TTM Avg	-11.55%
Current VS 3Y Avg	-11.55%
Current VS 5Y Avg	-11.55%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	574.45
Ev/Ebit Ratio Avg TTM	343.32
Ev/Ebit Ratio Avg 3Y	336.99
Current VS TTM Avg	+67.32%
Current VS 3Y Avg	+70.46%
Current VS 5Y Avg	+70.46%

Ev/Ebitda Ratio	203.78
Ev/Ebitda Ratio Avg TTM	147.75
Ev/Ebitda Ratio Avg 3Y	144.67
Current VS TTM Avg	+37.92%
Current VS 3Y Avg	+40.86%
Current VS 5Y Avg	+40.86%

Ev/Assets Ratio	12.01
Ev/Assets Ratio Avg TTM	9.22
Ev/Assets Ratio Avg 3Y	9.02
Current VS TTM Avg	+30.29%
Current VS 3Y Avg	+33.09%
Current VS 5Y Avg	+33.09%

Ev/Sales Ratio	20.76
Ev/Sales Ratio Avg TTM	16.63
Ev/Sales Ratio Avg 3Y	16.30
Current VS TTM Avg	+24.84%
Current VS 3Y Avg	+27.36%
Current VS 5Y Avg	+27.36%

Current Ratio	1.85
Current Ratio Avg TTM	1.72
Current Ratio Avg 3Y	1.74
Current VS TTM Avg	+7.53%
Current VS 3Y Avg	+6.01%
Current VS 5Y Avg	-6.11%

Quick Ratio	0.92
Quick Ratio Avg TTM	0.83
Quick Ratio Avg 3Y	0.84
Current VS TTM Avg	+11.12%
Current VS 3Y Avg	+9.34%
Current VS 5Y Avg	-17.30%

ROIC	2.56%
ROIC Avg 3Y	5.42%
ROIC Avg 5Y	7.81%
Current VS 3Y Avg	-52.88%
Current VS 5Y Avg	-67.28%
Current VS 10Y Avg	-74.13%

ROA	(1.18%)
ROA Avg TTM	(0.20%)
ROA Avg 3Y	0.44%
Current VS TTM Avg	-481.88%
Current VS 3Y Avg	-370.77%
Current VS 5Y Avg	-204.79%

ROE	(2.97%)
ROE Avg TTM	(0.05%)
ROE Avg 3Y	12.21%
Current VS TTM Avg	-6161.91%
Current VS 3Y Avg	-124.32%
Current VS 5Y Avg	-116.78%

Net Profit Margin	(2.03%)
Net Profit Margin Avg TTM	(1.55%)
Net Profit Margin Avg 3Y	2.40%
Current VS TTM Avg	-30.71%
Current VS 3Y Avg	-184.66%
Current VS 5Y Avg	-129.25%

Gross Profit Margin	46.69%
Gross Pft Margin Avg TTM	46.37%
Gross Pft Margin Avg 3Y	48.32%
Current VS TTM Avg	+0.70%
Current VS 3Y Avg	-3.38%
Current VS 5Y Avg	-5.99%

Tax Rate	13.74%
Tax Rate Avg 3Y	28.15%
Tax Rate Avg 5Y	26.55%
Current VS 3Y Avg	-51.20%
Current VS 5Y Avg	-48.25%
Current VS 10Y Avg	-46.20%